Molecular Neuropathology 2.0 - MNP2.0
The area of molecular neuropathology is rapidly expanding. We aim at providing reliable molecular analyses for both, well established and experimental diagnostic markers thereby meeting the demand from our clinical partners. Many analyses are performed and developed in close association with the Pediatric Targeted Therapy program and INFORM study. But also beyond these studies we are prepared to adapt our molecular diagnostic assays to the needs of individual study protocols.
All molecular analyses are done in close association with the Clinical Cooperation Unit Neuropathology.
 
The MNP2.0 study is now open for every primary brain tumor patient diagnosed and treated in Germany. If you are interested, please fill in our registration and shipment form, always obtain written consent (see below; German only), and register via the Brain Tumor Reference Center in Bonn. If you have any questions, please contact Dr. Dominik Sturm (via This email address is being protected from spambots. You need JavaScript enabled to view it.).
 
DKKS Logo 2016 11 07
The MNP2.0 study is funded by the Deutsche Kinderkrebsstiftung.